RecruitingNCT07589647
Research on the Efficacy and Safety of Targeted Suprachiasmatic Nucleus Electrical Stimulation for Improving Metabolic Disorders in Patients With Stable Bipolarity Comorbid With Obesity
Placebo comparisonAges 18–45China
Understand this study
Who could participate?
This study is for people with bipolarity. Listed age limits: 18 years to 45 years. Other eligibility criteria apply.
- Listed locations
- HangzhouSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: April 27, 2026
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 70
- Sponsor
- First Affiliated Hospital of Zhejiang University
- Sponsor type
- University
- Study type
- Other
- Intervention type
- Other
- Locations
- China
- Age range
- From 18 Years to 45 Years
- Official registry ID
- NCT07589647
- Official title
Show the full official title
Research on the Efficacy and Safety of Targeted Suprachiasmatic Nucleus Electrical Stimulation for Improving Metabolic Disorders in Patients With Stable Bipolar Disordercomorbid With Obesity
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Hangzhou
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is First Affiliated Hospital of Zhejiang University, a university.
Who can participate?
This study is for people with bipolarity. Listed age limits: 18 years to 45 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as recruiting.
